Company / Current Assets
Pfizer Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$42.9B
FY2025
5-year range
$42.9B / $59.7B
FY2021-FY2025
Trend
-14.8%
vs FY2024
Sector context
#4 of 213
Health Care
What the data says
Among 213 Health Care companies, Pfizer is in the top 2% for current assets. Current Assets has fluctuated over the past 10 years, ranging from $32.8B in FY2019 to $59.7B in FY2021.
Based on SEC 10-K filings.
$42.9B in FY2025 with a 5-year CAGR of +4.1%. Top quartile in the Health Care sector.
Remained stable around $42.9B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -5.8%
- 5-Year CAGR
- +4.1%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 213This company $42.9B Sector average $2.5B
▼
+1600.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +4.1%, indicating consistent growth.
- In FY2025, current assets decreased 14.8% year-over-year.
- Ranks #4 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.9B | -14.8% |
| FY2024 | $50.4B | +16.2% |
| FY2023 | $43.3B | -15.5% |
| FY2022 | $51.3B | -14.1% |
| FY2021 | $59.7B | +70.2% |
| FY2020 | $35.1B | +6.9% |
| FY2019 | $32.8B | -34.3% |
| FY2018 | $49.9B | +21.4% |
| FY2017 | $41.1B | +5.6% |
| FY2016 | $38.9B | -11.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026